Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

If Crede gets the maximum 3,834,508 shares at 2.00 (which does seem very likely), it will be interesting to see what PRs Navidea puts out within the two months following March 24th to help their pals at Crede squeeze as much money as possible out of the stock.

This situation is disgusting and shareholders deserved better! If a buyout happens before the end of 2014, I hope Crede is long gone and does not benefit from a buyout - especially if the buyout price turns out to be higher than 2.90. 2.90 is likely the highest price Crede got for any shares when they sold in October 2013.